Efficient infection of primitive hematopoietic stem cells by modified adenovirus

Gene Therapy

Volumn 8, Issue 12, 2001, Pages 930-937

  Yotnda, P ^a   Onishi, H ^a   Heslop, H E ^a   Shayakhmetov, D ^b   Lieber, A ^b   Brenner, M ^a   Davis, A ^a  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

CD34 lineage cells; CD40 ligand; Chimeric adenovirus Ad5 F35; Hematopoietic progenitor cells; Interleukin 2; SP cells

Indexed keywords

CD34 ANTIGEN; CD40 ANTIGEN; GREEN FLUORESCENT PROTEIN; GROWTH FACTOR; INTERLEUKIN 2; LIGAND; VIRUS PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ADENOVIRUS 5; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL CULTURE; CELL IMMORTALIZATION; CELL STRAIN K 562; CELL SUBPOPULATION; CELL SURFACE; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; EXPOSURE; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC ENGINEERING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE; VIRUS INFECTION;

ADENOVIRIDAE; ANTIGENS, CD34; CD40 LIGAND; CELL LINE; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 0034955129     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301488     Document Type: Article

References (56)

1. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
2. Engraftment and retroviral marking of CD34+ and CD34+CD38- human hematopoietic progenitors assessed in immune-deficient mice
3. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy
4. Retrovirus-mediated gene expression in hematopoietic cells correlates inversely with growth factor stimulation
5. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors
6. Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources
7. Selective elimination (purging) of contaminating malignant cells from hematopoietic stem cell autografts using recombinant adenovirus
8. Adenoviral vector-mediated gene transfer to primitive human hematopoietic progenitor cells: Assessment of transduction and toxicity in long-term culture
9. Maturation and lineage-specific expression of the coxsackie and adenovirus receptor in hematopoietic cells
10. Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: Implications for anatomical localization and developmental stage specific regulation of hematopoiesis
11. + cell populations derived from human umbilical cord blood using flow cytometry and cDNA-polymerase chain reaction
12. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector
13. Human adenovirus-host cell interactions: Comparative study with members of subgroups B and C
14. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F
15. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species
16. The critical role of CD40/CD40L in the CD4-dependent generation of CD8+ T cell immunity
17. The role of CD40 in peripheral T cell tolerance and immunity
18. Role of CD40 antigen and interleukin-2 in T cell-dependent human B lymphocyte growth
19. Functions of CD40 on B cells, dendritic cells and other cells
20. The dual role of IL-2 in the generation and maintenance of CD8+ memory T cells
21. Interleukin-2-dependent autocrine proliferation in T-cell development
22. Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBC-associated lymphoproliferative disease
23. Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: Results of a phase I clinical trial
24. Interleukin-2: Developing additional cytokine gene therapies using fibroblasts or dendritic cells to enhance tumor immunity
25. IL-2 adenovector-transduced autologous tumor cells induced antitumor immune responses in patients with neuroblastoma
26. Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: A phase I study
27. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5
28. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment
29. Adenovirus-receptor interaction with human lymphocytes
30. Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery
31. Adenovirus vector infection of chronic lymphocytic leukemia B cells
32. Efficient adenovirus-mediated gene transduction of normal and leukemic hematopoietic cells
33. Efficient adenoviral vector transduction of human hematopoietic SCID-repopulating and long-term culture-initiating cells
34. Transfer of genes to humans: Early lessons and obstacles to success
35. Lipofectamine and related cationic lipids strongly improve adenoviral infection efficiency of primitive human hematopoietic cells
36. Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens
37. Transduction of bone marrow cells by the AdZ.F(pK7) modified adenovirus demonstrates preferential gene transfer in myeloma cells
38. Adenovirus types 11p and 35p show high binding efficiencies for committed hematopoietic cell lines and are infective to these cell lines
39. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism
40. Adenovirus type 5 and 7 capsid chimera: Fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes
41. A chimeric type 2 adenovirus vector with a type 17 fiber enhances gene transfer to human airway epithelia
42. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein
43. A functional comparison of CD34+CD38- cells in cord blood and bone marrow
44. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo
45. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation
46. Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen
47. Analysis of T-cell defects in the specific immune response against acute lymphoblastic leukemia cells
48. Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma
49. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells
50. Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome
51. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM
52. CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia
53. CD40 ligand induces an antileukemia immune response in vivo
54. Cd40 ligand in CLL pathogenesis and therapy
55. Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice
56. High throughput method for creating and screening recombinant adenoviruses